Back to company

BIOLIT ApS: Financial statements 2025

CVR: 10068460

BIOLIT ApS (CVR 10068460) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 125,902 and a net result of DKK -20,616,619 compared with DKK 13,041,006 the year before. That is an increase of 109.1% compared with the year before. Equity amounted to DKK 10,762,624. The solvency ratio was 41.5%.

Gross Profit
125,902 kr.
Profit/Loss
-20,616,619 kr.
Equity
10,762,624 kr.
Total Assets
25,927,187 kr.
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-126 t.-20.6 mio.10.8 mio.0
2024-60 t.13 mio.31.4 mio.0
2023-974 t.4.8 mio.18.3 mio.0
2022-2.4 mio.3.2 mio.13.6 mio.0
2021-1.8 mio.1.6 mio.10.4 mio.0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like BIOLIT ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

About BIOLIT ApS

BIOLIT ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Flemming Velin. The company is owned by SCANVET ANIMAL HEALTH A/S. The company has 3 employees. In 2025, the company reported a gross profit of DKK 125,902 and a net result of DKK -20,616,619 compared with DKK 13,041,006 the year before. Equity amounted to DKK 10,762,624.